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DEFINITIONS OF TERMS 
 
Pulmonary tuberculosis: Refers to the disease involving the lung parenchyma 
caused by micro bacteria tuberculosis.  
TB Non-adherent: A patient whose treatment was interrupted for two consecutive 
months or more.  
TB Non-defaulter: A patient who has successfully been treated for TB for a period 
of six months without interruption. 
Treatment complete: Patient who has taken TB treatment for six months without 
interruption and at the end of treatment the smear result is unknown. 
Perception: It is the way of seeing or understanding something, in this study 
perception means the opinions of TB patients. 
Knowledge:  Information and skills acquired through experience or education. In this 
study knowledge means being informed about TB issues. 
Attitude: Settled way of thinking or feeling, a position of the body indicating a 
particular mental state. In this study attitude means feelings of TB patients. 
Cure: A patient whose sputum is positive at the beginning of treatment and smear 
negative in the last month of treatment and on at least one previous occasion.  
New cases: A patient who is diagnosed with TB for the first time and has never been 
treated for TB or who has taken anti-tuberculosis drugs for less than one month. 
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ABSTRACT 
 
 
Background: Tuberculosis (TB) in the majority of cases is a curable disease requiring 
prolonged treatment of six months. The World Health Organisation (WHO) recommends 
the Direct Observation Treatment Short course (DOTS) strategy as the approach to 
control TB. Despite such interventions, defaulting from TB treatment is still a major 
problem among TB patients at Botšabelo Clinic in Maseru. This research aimed to 
describe knowledge, attitudes and perceptions to TB as a disease and its treatment among 
non-adherent and adherent at Botšabelo Clinic in the Maseru district of Lesotho, in order 
to identify contributing factors related to defaulting treatment. 
 
Study design: A cross-sectional descriptive study was conducted. 
 
Population and sampling: TB non-adherent and adherent registered at Botšabelo Clinic 
in 2007 were included in the study. Simple random sampling was used to select both non-
adherent and adherent. 
 
Data collection: Data were collected by means of a structured questionnaire. 
 
Data analysis: Epi-Info Version 3.4.3 was used for data analysis. Descriptive statistics 
were calculated using frequencies, means and percentages for socio-demographic 
information, knowledge, attitudes and perceptions. A p-value of less than 0.05 was 
accepted as being statistically significant in all statistical tests. 
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Results: The total number of respondents who were interviewed in this study was 283. 
131(46%) were non-adherent and 152 (54%) were adherent. Non-adherent and adherent 
showed good knowledge of symptoms, prevention and transmission of TB. They were 
also knowledgeable about duration of treatment. 98% non-adherent and 100% adherent 
knew that TB is curable. 93% non-adherent and 93% adherent visited a health facility 
when TB symptoms occurred. 
 
Less than half of the respondents (47% non-adherent and 47% adherent) smoked. 47% 
non-adherent 43% adherent drank alcohol. Many non-adherent and adherent experienced 
support from the community. A large number mentioned that TB did not affect their 
marriage negatively. 
 
Conclusion: Non-adherent and adherent showed good knowledge of symptoms, 
prevention, disease transmission and definition of TB. Even though many could define 
TB, there were misconceptions that TB is caused by poison. Therefore, there is a need to 
strengthen health education on TB among communities. They were also knowledgeable 
that TB is curable and many could define DOT. Their attitudes and perceptions towards 
TB as a disease were positive. Many (93%) of those who were diagnosed with TB went 
to a health facility for treatment, while others sought it from traditional healers. Less than 
half of non-adherent and adherent delayed seeking treatment. A considerable number of 
non-adherent and adherent were heavy smokers. Alcohol intake was moderate among 
both groups. 
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 Media was reported as the main source of TB information in this study. Side effects to 
medication were the most reported deterrent to treatment among non-adherent. The side 
effect with the highest frequency was vomiting. It was followed by nausea and skin rash.  
Socio-economic factors that determined treatment were access to health services, long 
distance to the clinic, lack of transport and lack of funds and personal habits like smoking 
and alcohol abuse. Delay in seeking treatment was found to be a problem in this study. 
There was no difference found between knowledge attitude and perceptions of non-
adherents and adherents. 
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CHAPTER 1 
 
1. INTRODUCTION 
 
1.1 BACKGROUND INFORMATION 
Lesotho is a small mountain Kingdom situated in the southern part of Africa, completely 
surrounded by the Republic of South Africa. The capital city is Maseru, the population is 
1.8 million. It is divided into ten administrative districts namely: Berea, Butha-Buthe, 
Leribe, Mafeteng, Maseru, Mohaleshoek, Mokhotlong, Qachasnek, Quthing and Thaba-
Tseka. Lesotho can be distinguished by high altitude terrain (LDHS, 2004). This country 
is divided into two residential areas, urban and rural and further divided into four 
ecological zones: lowlands, foothills, mountains and Senqu valley. More than 80% of the 
country is higher than 1,800 metres above sea level. The major natural resources are 
water, agriculture and mining in small scale, only 10% of the land is arable. It is a less 
resourced country ranked at 149 in the United Nations Human Development scale. The 
Gross Domestic Product per capita (GDP) for Lesotho is $1,351.06 (IMF 2011). 
 
Tuberculosis (TB) is an infectious curable disease. In Lesotho, TB treatment is without 
charge at all levels of care. Health care workers and community health workers are 
trained to manage TB with standardised World Health Organisation (WHO) protocols. 
Despite the free TB treatment and implementation of Direct Observation Treatment Short 
course (DOTS), 20.8% of TB patients at Botšabelo Clinic in the district of Maseru 
defaulted treatment in 2007 (MOHSW, 2007a). 
 
TB is still a major cause of death worldwide (WHO, 2007). The World Health 
Organisation (WHO) estimates that about one third of the global population is infected 
 
 
 
 
  
 
2 
 
with TB and it is at risk of developing the disease. In 2007, there were an estimated 8.8 
million newly reported TB cases worldwide. Asia and Sub-Saharan Africa reported 7.4 
million (84%) cases in 2007. A total of 1.6 million people died of TB including 195,000 
people infected with HIV worldwide (WHO, 2008b). 
 
The 2011 WHO Global Tuberculosis Report ranked Lesotho 5
th
 among 15 countries of 
the world with the highest per capita incidence (NTP, 2009). In 2007, Lesotho reported 
14,300 TB cases (4,278 new pulmonary smear positive, 555 relapses, 2,853 new smear 
negative, 1,041 non-adherent and 1,676 re-treatment cases) of all forms of TB. Maseru 
district alone contributed 25% of new sputum smear positive TB cases. The incidence of 
all cases and new smear positive cases was 768 per 100,000 population and 212 per 
100,000 population respectively, with an estimated case detection rate of 80% for new 
sputum smear positive cases.  Out of the 11,436 new cases reported, patients with smear 
positive TB accounted for only 35% (4,024) of all notified cases as opposed to the 
expected 50%. This was attributed to the high incidence of HIV in the country because 
most TB cases are sputum negative (MOHSW, 2008b).  
 
In the same year Botswana reported 13,761 new cases of TB while Swaziland reported 
13,674. New smear positive cases and smear negative cases for Botswana and Swaziland 
were 5,251 and 5,055 and 8,510 and 8,519 respectively. (WHO, 2007) 
 
In 2011 Lesotho reported 12,616 TB cases of which 10,400 were new cases. Of the 
10,940 notified new cases 3,510 were new pulmonary sputum smear positive, 3,242 were 
new smear negative and 2,089 were extra-pulmonary cases. 2,099 were sputum smear not 
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done. The data showed that treatment success rate declined from 72% to 68.8% (NTP, 
2010). 
 
Lesotho adopted the Direct Observation Treatment Short course (DOTS) strategy in 
1994. The country also adopted the DOTS strategy as a way of increasing compliance 
amongst patients. Patients are observed by a health care worker or a community health 
worker (CHW) for a period of two months in the initial phase, followed by six months 
during the continuation phase. On discharge, a patient is handed a treatment card with 
dates and days where a DOT supporter can tick on a daily basis as the patient takes drugs. 
This clinic card is checked by a health care worker every time the patient comes for 
refills. A duplicate of the card is kept at the clinic (MOHSW, 2007b). The goal of this 
programme is to cure at least 85% new smear positive patients; and to detect at least 70% 
of new smear positive cases in the community. The country is reporting 100% DOTS 
implementation and according to 2007 data, the success rate was 72% and detection rate 
was 86% which is far above the expected 70% set by WHO (MOHSW, 2007b). 
 
Botšabelo is a referral clinic for the management of TB patients.  All patients suspected 
with TB are referred to the centre for diagnosis and treatment. At this clinic, health care 
workers observe National TB and WHO recommended guidelines at all times. Once 
diagnosed with TB, patients‟ names and addresses are entered in the TB register prior to 
providing them with free medication. Drugs are ordered in line with the national TB 
guidelines (MOHSW, 2007b). 
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 DOT is a community-driven strategy in which members of the community participate 
voluntarily as DOT supporters. They are trained by health care workers on how to 
supervise TB patients when taking treatment in their homes. The DOT supporter has an 
important role to play. He/she is required to remind and to encourage patients on TB 
treatment to continue until the last dosage is taken (MOHSW, 2007b; WHO, 1994). 
Furthermore, they communicate with patients‟ families, provide health education to their 
communities and they are charged with the responsibility of tracing non-adherent 
patients. These supporters are paid on monthly basis (MOHSW 2006).  
 
Although TB patients are provided with adequate information on TB treatment and the 
importance of completing it when they attend clinics, there are still those who do not 
complete treatment, especially in Maseru. As a result, I, the researcher decided to 
describe knowledge, perceptions and attitudes of TB non-adherent and adherent. 
 
WHO (1994) recommends DOTS as the international strategy for TB control 
programmes. Tenets of DOTS include:   
 Government commitment to the national TB programme 
 Case detection through smear microscopy 
 Standardised treatment of TB cases 
 Regular, uninterrupted drug supply 
 Good system of monitoring and evaluation 
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The new Stop TB Strategy (2006-2015) builds on the achievements of the DOTS 
strategy. It embraces fundamentals of TB control originally framed as DOTS. But, it 
extends the reach of control activities to other key areas. These areas include multi-drug 
resistant TB (MDR-TB) and Extreme Drug Resistant TB (DOTS-PLUS). (NTP, 2009)  
 
Components of the new Stop TB Strategy are as follows: 
Pursue high-quality DOTS expansion and enhancement 
 Secure political commitment, with adequate and sustained financing  
 Ensure early case detection, and diagnosis through quality-assured bacteriology  
 Provide standardized treatment with supervision, and patient support  
 Ensure effective drug supply and management  
 Monitor and evaluate performance and impact 
 Address TB-HIV, MDR-TB, and the needs of poor and vulnerable populations 
 Implement collaborative TB/HIV activities  
  Prevention and management of multi-drug resistant TB (MDR-TB)  
 Address the needs of TB contacts, and of poor and vulnerable populations 
Contribute to health system strengthening based on primary health care  
 Help improve health policies, human resource development, financing, supplies, 
service delivery and information  
 Strengthen infection control in health services, other congregate settings and 
households  
 Upgrade laboratory networks, and implement the Practical Approach to Lung 
Health (PAL) 
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 Adapt successful approaches from other fields and sectors, and foster action on 
the social determinants of health 
Engage all care providers 
 Involve all public, voluntary, corporate and private providers through Public-
Private Mix (PPM) approaches  
 Promote use of the International Standards for Tuberculosis Care (ISTC)  
Empower people with TB, and communities through partnership 
 Pursue advocacy, communication and social mobilization  
 Foster community participation in TB care, prevention and health promotion  
 Promote use of the Patients' Charter for Tuberculosis Care  
Enable and promote research 
 Conduct programme-based operational research  
 Advocate for and participate in research to develop new diagnostics, drugs and 
vaccines (WHO, 2006) 
The assumption is that trained observers will watch patients take treatment. Moreover, 
adherence to treatment still remains the prerogative of the individual patient. 
 
1.2 PROBLEM STATEMENT 
Lesotho has been reporting low success rate of 72% according to WHO report 2007, 
despite the fact that government is directing massive resources towards prevention and 
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cure of TB. It is on this background that the researcher decided to describe and compare 
knowledge, attitudes and perceptions of clients 2-3 years after their initial registration.  
 
1.3 RATIONALE FOR THE STUDY 
 
Lesotho has the highest incidence of TB in the world (WHO, 2007). The number of TB 
patients defaulting from treatment increased from 11% in 2006 to 20.8% in 2007 (NTP, 
2009). The research therefore described the knowledge, attitudes and perceptions of TB 
as a disease and its treatment among non-adherent and adherent. The information 
acquired in this study will assist in understanding the gaps in knowledge, experience and 
perceptions therefore assist in the development of appropriate interventions for the 
management of TB.  
 
1.4 BACKGROUND 
1.4. 1 TUBERCULOSIS (TB) PROGRAMME IN LESOTHO 
The following section will explore the background and the structure of the TB 
programme in Lesotho more extensively; the DOTS strategy; diagnosis and treatment of 
TB; management of interruption; TB/HIV; and MDR-XDR. Furthermore, this section 
will explore the background and the context of the research problem through a critical 
review of past and recent studies on knowledge, attitudes and perceptions of TB patients 
and TB treatment. 
 
1.4.2 OBJECTIVES OF TB CONTROL PROGRAMME IN LESOTHO 
The TB control programme in Lesotho has the following objectives: 
 To strengthen DOTS implementation through the training of health workers, 
traditional healers and extension workers in TB Control 
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 To improve quality for TB diagnosis through the establishment of a quality 
control system in all health service areas(HSAs) 
 To strengthen and to expand public-private partnerships in DOTS implementation 
through training of general practitioners 
 To improve National Tuberculosis Programme (NTP) management by ensuring 
that all district hospitals use TB surveillance data for monitoring and evaluation   
 
1.4.3 ORGANIZATION OF TB SERVICE DELIVERY 
The management and organization of TB services at the district level is the responsibility 
of the District Health Management Teams (DHMTs) discharged through the NTP focal 
person, who is the District TB Coordinator (DTBCO) (NTP, 2009; MOHSW, 2008a). 
Currently, each hospital has at least one TB Officer (TBO) under the supervision of the 
DTBCO and Hospital Management Team (HMT). TBOs coordinate and implement the 
NTP policy at hospital, health centre and community levels (NTP, 2009). Under the 
national monitoring and evaluation plan, all data and health information flows from the 
districts to one focal point in the Health Planning and Statistics Unit (HPSU) of the 
Ministry of Health from where programmes and other departments access it for their 
managerial use (MOHSW, 2007b). 
 
1.4.4 NATIONAL TUBERCULOSIS PROGRAMME (NTP) STRUCTURE 
The NTP was established in 1986. It is fully funded by the Government of Lesotho. It is 
one of the sub-units of the Disease Control Unit (DCU). The DCU is charged with the 
management and control of communicable and non-communicable diseases. The NTP 
Manager reports directly to the Head Disease Control Unit. 
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At the district level, the District TB Coordinator (DTBCO) directly supervises the District 
TB Officers (TBOs) who are responsible for TB case registration and treatment at health 
facilities. At community level, the community DOT supporter reports to a health centre 
nurse. The community health worker supervises the patient on daily basis, provides health 
education to the patient and family. The drugs and the card are kept by the CHW at health 
post. The patients are referred back to the clinic for sputum examination before 
completion of treatment. (NTP, 2009). 
 
At community level, various stakeholders including  community health workers (CHWs),  
non-governmental organisations (NGOs), community based organisations (CBOs), TB 
treatment supporters and traditional healers in their varying capacities deliver TB care in 
close collaboration with the district team (NTP, 2009). 
 
The central TB reference laboratory is housed within the premises of Queen Elizabeth II 
Hospital, the national referral hospital in Maseru. Sputum, culture examination, and drug 
susceptibility testing (DST) are performed in this laboratory. Medical Research Council 
(MRC) South Africa is mandated to conduct external quality assessment under the WHO 
supranational reference laboratory network (NTP, 2009). 
 
A network of 18 laboratories throughout the country performs sputum smear microscopy, 
whilst the central TB reference laboratory serves as the quality assurance laboratory for 
sputum smears. DST is now performed at a central laboratory with assistance from the 
Foundation of Innovative New Diagnostic (FIND) (MOHSW, 2007a). 
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The National Drug Service Organisation (NDSO) is responsible for procurement and 
distribution of medicines to MOHSW and Christian Health Association of Lesotho 
(CHAL) institutions. First-line anti-TB drugs are procured from Global Drug Facility 
(GDF) and are supplied free of charge to all patients. Second-line drugs are supplied by 
Green Light Committee (GLC) (MOHSW, 2007b). 
 
1.4.5 DOTS STRATEGY 
The five components of this strategy are: 
 Sustained political commitment 
Government must commit financial and human resources in support of the TB 
programme.  
 Case detection through quality-assured bacteriology 
Case detection must occur among symptomatic patients self-reporting to health 
services, using sputum smear microscopy.  
 Standardised treatment with supervision and patient support 
This includes standardised short-course chemotherapy that uses regimens of 6–8 
months for at least all confirmed smear-positive cases; and directly observed 
treatment (DOT) during the intensive phase for all new smear-positive cases, 
during the continuation phase of regimens containing rifampicin and during the 
entirety of a re-treatment regimen.  
 An effective drug supply and management system 
Establish and maintain a supply system for quality-assured, essential anti-TB 
drugs and to ensure no interruption in their availability.   
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 Monitoring and evaluation system and impact measurement 
Establish and maintain a standardised recording and reporting system that allows 
assessment of treatment results of all patients.  
 
1.4.6 ENSURING PATIENTS’ COMPLIANCE VERSUS NON-ADHERENT 
TRACING 
Patients‟ compliance is a key factor in treatment success. In many parts of the country, a 
significant number of patients stop taking drugs before completion of treatment for 
various reasons. The premature interruption of treatment is problematic to patients, their 
family members, those who care for them, and to health workers (NTP, 2009; Tekle, 
Mariam & Ali, 2002). 
 
Promoting compliance through a patient-centred approach includes facilitating access to 
treatment; choosing with the patient the most convenient time and place for direct 
observation of treatment; and where possible, providing other social and medical services 
rather than wasting resources on tracing non-adherent. Facilitating access includes 
providing drugs and sputum smear examinations free of charge; reducing time and cost to 
the patient to obtain treatment; and providing good and rapid attention (NTP, 2009; Khan, 
Imdad, Newell & Walley, 2000). 
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1.4.7 PREVENTIVE MEASURES TO DECREASE TREATMENT 
INTERRUPTION 
When a TB patient is treated for the first time the health worker has  to set aside enough 
time to meet with him/her (and preferably also with his/her family members). This is a 
significant opportunity to advice and counsel the patient (WHO, 2004). During this 
meeting, it is vital to record the patient‟s and his/her relatives‟ details (physical and 
work/home telephone addresses) in order to maximise the probability of locating patients 
who interrupt treatment (NTP, 2009).  
Management of treatment interruption 
The management of patients who have interrupted treatment is complex and takes into 
consideration several variables (immune status, degree of remission of the disease with 
the previous treatment, drug susceptibility) that may be difficult to assess. A simple 
decision tree is depicted in Table 1 below. 
 
Table 1: Management of treatment interruption (Default) (NTP, 2009) 
Interruption for less than 1 month 
 Trace patient 
 Solve the cause of interruption 
 Continue treatment and prolong it to compensate for missed doses 
Interruption for 1 – 2 months 
Action 1                                                                 Action 2 
 Trace patient 
 Solve the cause of the 
interruption 
 Do 3 sputum smears 
 Continue treatment 
while waiting for 
results 
If smears  
negative or  
EPTB 
Continue treatment and prolong it to compensate for missed doses 
If one or more  
smears positive 
Treatment received: 
< 5 months 
Continue treatment and prolong it to  
compensate for missed doses 
Treatment received: 
> 5 months 
Category I: Start category II 
Category II: refer (may evolve to chronic) 
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Interruption for 2 months or more (defaulter) 
 Do 3 sputum smears 
 Solve the cause of the 
interruption, if 
possible 
 No treatment while 
waiting for results 
If smears 
negative  
or EPTB 
Clinical decision on individual basis whether to restart or continue 
treatment 
 Category I Start Category II 
Category II Refer (may evolve to chronic) 
 
 
TB/HIV management 
The HIV epidemic is causing a rapid increase in TB (WHO, 2005). HIV-infected 
individuals are at risk of developing active TB due to either reactivation of latent 
infection with mycobacterium TB or rapid progression of newly acquired infections 
(WHO, 2004). TB is the most common opportunistic infection in people living with 
HIV/AIDS. When TB develops in an HIV infected person the prognosis is very poor. 
 
The HIV prevalence of 23.2% in Lesotho is one of the highest in Sub-Saharan Africa 
(MOHSW, 2006). The first case was diagnosed in 1986. Since then, the prevalence 
sharply rose from 2% in 1992 to 21% by 2000 (AIDS Policy, 2006). HIV seroprevalence 
conducted among TB patients in three sentinel sites in Lesotho showed levels of 15.4% in 
1993 and 39.8% in 1995. In urban areas like Maseru, the estimated prevalence of HIV in 
TB patients was 50%. The proportion of TB patients infected with HIV was 76% in 2007 
(WHO, 2007). 
 
The national response to HIV/TB has been intensified since 2002, but with no 
collaborative linkages in the implementation of both programmes. This is evidenced by 
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the implementation of “specific HIV and AIDS interventions comprising of information 
education and communication materials (IEC) to promote awareness and behavioural 
change for specific target groups, HIV testing and counselling, home-based care, 
HIV/AIDS surveillance, blood safety and laboratory support” (MOHSW, 2008). 
Mechanisms are under way to increase HIV/TB collaborative activities (NTP, 2009). 
 
The HIV/AIDS programme implements specific interventions such as IEC materials to 
promote: awareness among the general public; voluntary counselling and testing; home 
based care; and HIV/AIDS counselling. Lesotho adopted the Know Your Status (KYS) 
campaign as a way of encouraging the nation to test for HIV/AIDS. Since 2007, the 
number of TB/HIV activities has increased dramatically. Benefits of these activities 
include: 
 Harmonizing of TB and ART activities 
 Commencement of joint planning and programming between NTP and the             
HIV/AIDS directorate 
 Capacity-building towards screening of people living with HIV/AIDS 
 Capacity-building towards screening of TB patients 
 Provision of cotrimoxazole to all HIV positive TB patients 
 Development of joint monitoring and evaluation plan 
 
In TB/HIV collaborative activities, all patients who are diagnosed with TB are screened 
for HIV, and all patients who are HIV positive are screened for TB for early detection of 
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TB and initiation of prophylaxis. It is very important to exclude TB before starting the 
INH prophylaxis to prevent MDR-XDR TB (AIDS Policy, 2006). 
 
Management of MDR-XDR TB 
Management of MDR imposes a tremendous challenge to National TB programmes 
especially in resource-limited settings (Camirero, 2010). MDR-TB is defined as 
resistance against at least isoniazid and rifampicin. It is a very serious form of             
drug-resistant TB as isoniazid and rifampicin are the most potent bactericidal drugs for 
treatment of TB (Chiang & Schaaf, 2010; MDR, 2007). All other drugs are less potent 
and have more side effects. 
 
Treatment without these two drugs is always much longer and cumbersome (MDR, 2007; 
Camirero, 2010). DOTS strategy has been proven to prevent emergence of MDR-TB. 
Where DOTS strategy is not well implemented MDR-TB occurs (MDR, 2007; WHO, 
2008c). 
 
The two kinds of drug-resistant TB are primary resistance and acquired drug resistance.  
Primary resistance occurs in patients who have never been treated for TB before, and 
acquired drug resistance occurs when a patient has been previously treated for TB for 
more than a month. (Chiang & Schaaf, 2010; MDR, 2007; WHO, 2006). 
 
Like all other countries, Lesotho has adopted MDR standardized treatment as 
recommended by WHO. Most MDR-TB patients are treated on an ambulatory basis. The 
very ill are admitted to hospital. On discharge, each patient is followed up by a trained 
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TB supporter. The supporter provides the patient with clinical follow-up until completion 
(MOHSW, 2006; MDR, 2007). 
 
Management teams manage MDR-TB patients at district level. Their responsibilities 
include patients counselling and monitoring of side effects. Treatment of MDR-TB is 
initiated as soon as two separate sputum specimens have been sent to the laboratory for 
culture and DST. The initial phase lasts for six months and/or until the culture is 
negative.  The continuation phase lasts for 18-24 months (MDR, 2007; WHO, 2008c). 
 
1.5 STRUCTURE OF THE MINI-THESIS 
Chapter one briefly describes the background, the problem, the purpose and the approach 
to the study. It also highlights the rationale for the research topic. This chapter also 
explains the structure of the TB programme in Lesotho and the DOTS strategy; and it 
discusses diagnosis and treatment of TB; management of interruption; TB/HIV; and 
MDR-XDR. 
 
Chapter two discusses the literature review. It explores the context of the research 
problem more extensively through a critical review of past and recent studies on 
knowledge, attitudes and perceptions of TB patients. 
 
Chapter three describes the research aims and objectives; methodology and study design; 
sampling procedure; data collection methods and tools; data handling and analysis; as 
well as study limitations and ethical considerations. 
 
 
 
 
  
 
17 
 
 
Chapter four focuses on the results obtained from the study and includes an interpretation 
thereof. 
Chapter five discusses the study findings in relation to the literature. 
 
Chapter six outlines the conclusion and recommendations of the study. 
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CHAPTER 2 
2.  LITERATURE REVIEW 
 
Chapter two discusses the literature review. It explores the context of the research 
problem more extensively through a critical review of past and recent studies on 
knowledge, attitudes and perceptions of TB patients. 
 
2.1 INTRODUCTION 
TB continues to be one of the major health challenges worldwide, despite the world 
directing massive resources towards its prevention and cure. Problems encountered 
include the following: confirming the diagnosis is difficult, treatment to cure takes too 
long, drug resistant is increasing, BCG is only partially effective and our inability to slow 
down the spread of HIV more quickly than seems to be happening naturally.  WHO 
(1993) and the Maputo Declaration (2005) declared TB as an emergency in Africa 
(WHO, 2005). Determinants of TB are diverse and multifactorial. However, poor 
management of patients and fragmented health services are some of the barriers to 
effective TB control (Van der Walt, Weyer, Lancaster & Levin, 2002; Karyadi, 2002). 
 
Poor compliance to TB treatment has been cited as one of the major obstacles which have 
led to the spread of TB (Jaggarajamma et al 2007; Tekle et al, 2002). A plethora of 
reasons have been cited for defaulting and this includes patients stopping taking treatment 
due to lack of knowledge, poverty, migration, stigma and poor access to health services 
and unemployment (Holtz, Thorpe, Weyer, Matji & Larson, 2002; Khan et al, 2000). In 
addition, patients‟ perceptions about the negative attitudes of health workers and 
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substance and drug abuse have also been cited as reasons for defaulting (Van der Walt, 
Weyer, Brand, Lancaster & Levin, 2003).  
 
Non-compliance of TB patients to self-administered drugs is a common cause for failure 
of initial therapy and default. Some patients cited adverse reaction to treatment, lack of 
information about side effects and how to overcome them as reasons for discontinuing 
medication (Volmink & Garner, 2006; Khan et al, 2000). In addition, one study 
conducted in India revealed that one of the reasons for perceived side effects could be the 
continued practice of giving medication on an empty stomach (Vijay et al, 2010). 
   
2. 2 KNOWLEDGE ABOUT TB 
Lack of knowledge is one of the major determinants of treatment default (Homedes & 
Ugaide, 1993; Liam & Tang, 1995). A study conducted in Ethiopia revealed that 
compliance to DOTS was significantly high among those who had good knowledge about 
various aspects of the disease (Tekle et al, 2002). This was also confirmed by Pandit & 
Chaudhary (2006). Compliance was more among patients who possessed good 
knowledge about TB according to studies conducted in Thailand and Pakistan (Karyadi, 
2002; Mushtaq et al, 2010). 
  
Many studies have focused on the influence of patients‟ understanding of treatment, 
including its duration and the reasons for defaulting treatment (Jaggarajamma et al, 2007; 
Khan et al, 2000; O‟Boyle et al, 2002; Yadav, Murthur & Dixit, 2006; Liam, Lim, Wong 
& Tang, 1999; Wares, 2003). The long treatment period was poorly understood by 
patients and adherence was found mainly where people understood the importance of 
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long-term treatment (Khan et al, 2000; O‟Boyle et al, 2002). Patients who are 
knowledgeable about signs and symptoms of TB are less likely to default on treatment 
(Jaggarajamma et al, 2007; Pandit & Chaudhary, 2006). 
  
According to the study conducted in Pakistan on knowledge, attitudes and perceptions of 
TB patients, knowledge was significantly better among population groups with higher 
education, higher income and those living in urban areas with a p-value  less than 0.001 
(Mushtaq et al, 2010). A study conducted in Sudan found gender differences in 
knowledge. Males (58%) were more knowledgeable about signs and symptoms of TB 
than females (52.8%), p-value < (0.05) (Mohamed, Yousif, Ottoa & Bayoumi, 2007). In 
an Angolan study that measured the parameters of health-seeking intention among TB 
patients, it was found that knowing the key symptoms of TB was positively associated 
with appropriate health-seeking (OR 3.1, 95% CI 1.4-6.8) (Louis et al, 2011). 
 
In the former, 64.5% of the respondents interviewed identified cough as the main 
symptom of TB, fever (49.2%), fatigue (35.7%), weight loss (45.7%), chest pain (24.9%), 
and nausea (16.9%). Most of the subjects interviewed (68.2%) reported that covering the 
mouth and nose when sneezing is a preventative measure for TB. Among treatment 
options given in the study, respondents (82%) mentioned that TB is cured by TB drugs. 
They also mentioned that the duration of treatment is 6-9 months without interruption 
(Mushtaq et al, 2010). 
 
The propensity to seek care depends on knowledge about the perceived risk of TB within 
reference groups and communities at large (Karyadi, 2002; Pandit & Chaudhary, 2006). 
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A number of studies revealed a link between knowledge and default (Hill & 
Chamachandran, 1992; Homedes & Ugaide, 1993; Jaiswal, Singh, Ogden, Porter & 
Sharma, 2000). Knowledge includes the ability to recognise symptoms, identify causes 
and transmission routes, familiarity with the availability of cure and duration of treatment 
(WHO, 2008a). 
 
2. 3 ATTITUDES, PERCEPTIONS AND BELIEFS 
In a qualitative study by Khan and colleagues (2000), most of the patients in Pakistan 
believed that TB is a punishment from God. However, in Lesotho patients believe that 
TB is a poison in the lungs (sejeso) which is associated with bewitchment (MOHSW, 
2004). Such belief systems suggest that educational messages should include local 
context and address local beliefs and attitudes about TB and its treatment (Jaramillo, 
1999). 
 
It was found in some studies that patient beliefs about the efficacy of treatment, both 
positive and negative, may impact on adherence (Liam et al, 1999; Van der Walt et al, 
2002; Homedes & Ugaide, 1993). Patients with a higher perception of the severity of the 
disease are less likely to delay care-seeking and diagnosis and treatment (Kim, Mori & 
Shimao, 1985; Rally et al, 1998: Khan, et al, 2006; Pronyk, et al, 2001). 
 
According to the study conducted in Pakistan, the results revealed that respondents 
sought help for the first time from a health facility (95.3%), other choices were the 
pharmacy (3.5%), traditional healer (2.3%) (Mushtaq et al, 2010). In addition, 78.2% of 
the participants in this study sought treatment as soon as symptoms occurred, while 
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others delayed until after 3-4 weeks. The same study revealed that 47.9% of the 
respondents believed that TB patients are stigmatised by communities. The results further 
showed that literate TB patients were more likely to feel embarrassed and stigmatised 
than illiterate patients, while others feared and had feelings of hopelessness (Mushtaq et 
al, 2010). 
 
A descriptive exploratory study conducted in Vietnam among health workers and TB 
non-adherent on knowledge and attitudes of TB treatment revealed that TB was 
considered a dirty disease, which mainly affects poor people (Hoa, Thorson, Long & 
Diwan, 2003). Furthermore, patients with TB felt less respected by others. This social 
stigmatisation leads to delays in seeking treatment. The patient‟s economic status was 
also an important determinant of compliance and non-compliance (Hoa et al, 2003). 
 
2. 4 ALCOHOL AND SMOKING 
Worldwide studies confirm that smoking is an established risk factor not only for cancers, 
coronary heart disease and stroke, but also in the case of being infected with 
mycobacterium tuberculosis (Dujaili, Sulaiman, Awaisu, Muttalif & Blebil, 2010; Leung, 
Yew, Chan, Tam & Lam, 2003; Mauraya, Vijayan & Shah, 2002). 
 
Smoking, alcoholism and drug abuse have been found to increase treatment default (Sepa 
& Peltzer, 2005; Mauraya et al 2002, Hasker et al, 2008). In a study that investigated risk 
factors for default and time of default, results showed that unemployment, being a 
pensioner, alcoholism and homelessness were associated with treatment default; patients 
defaulted mostly during the intensive phase of the treatment (Hasker et al, 2008). A 
 
 
 
 
  
 
23 
 
retrospective study conducted in Malaysia to determine the prevalence of smoking among 
TB patients; and to compare the treatment outcomes between smoking and non-smoking 
TB patients, found that the prevalence of smoking among TB patients was high (53.4%). 
Smoking was significantly associated with male gender, alcohol use and intravenous drug 
use. Smokers had an increased likelihood of treatment failure (OR 7.48), default (OR 
7.17) and were less likely to be cured. (Dujaili et al, 2010).  The study concluded that the 
prevalence of smoking was high among TB patients in Malaysia; this was confirmed by a 
study conducted in China which revealed that 54.6% of TB patients were smokers (Dujaili 
et al, 2010).  
 
A study conducted by Pandit and Chaudhary (2006) reported that drinking alcohol was 
associated with unpleasant side effects such as vomiting. Patients who experience side 
effects are more likely to default TB treatment (Khan et al, 2000). 
 
The Lesotho Demographic Health Survey 2004 showed that 70% of women interviewed 
did not take alcoholic drinks while 42% of men took them. The study also revealed that 
men with higher education drank larger quantities of alcoholic drinks than their women 
counterparts. Men (42%) used tobacco products more than women (15%). 
 
2. 5 HEALTH EDUCATION 
Health education is concerned with informing and creating awareness among the general 
public or specific populations about TB; and empowering people to take action. Health 
education strategies are geared towards changing people‟s behaviours with regard to 
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taking TB medication (Wandwalo & Morkve, 2000; Jaramillo, 1999; Mahomed et al, 
2007). 
 
According to Jaramillo (1999), poor education on TB was the cause of treatment default 
by TB patients.  Most of the studies reported television and health workers as the main 
sources of information about TB (Mushtaq et al, 2010; Hoa et al, 2003; Khan et al, 2006). 
Therefore media can serve as an important medium for disseminating health information. 
 
The results of a study conducted in Nepal to assess knowledge and attitudes of TB 
patients and adherence to DOTS showed that 61% of respondents had insufficient 
knowledge about the need to take treatment daily, mainly after they felt better. DOTS, 
younger age, knowledge about TB and availability of daily health education were 
independently associated with adherence (OR 6.27; 95% CI 2.88 – 13.4; p-value<0.001) 
(Bam et al, 2006).  
 
Important educational messages about TB which patients should know have been 
suggested by Mohammed and colleagues (2007) and these include: What is TB? What 
are the causes of TB? How is it transmitted? What are the consequences of stopping TB 
treatment? What are the possible side effects? Treatment of TB; Do you know treatment 
duration? 
  
2. 6 STIGMATIZATION 
One major setback to the success of TB control globally is the stigma attached to the 
disease in most societies. TB is associated with stigma and discrimination and these have 
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a negative impact on health (Liam & Tang, 1995; Kim, Mori & Shimao, 1985).  This 
association was confirmed by studies conducted in Nepal and Ghana (Baral, Karki & 
Newell, 2007; Dodor, Neal & Kelly, 2008).  
 
A study conducted in Nepal found that TB patients‟ beliefs and behaviour were a major 
cause of self discrimination. Patients isolate themselves from family and friends because 
of fear of transmitting the disease to others and fear of being discriminated against (Baral 
et al, 2007). 
 
While a study conducted in Ghana found that TB stigma was caused by fear of infection, 
physical frailty, associating TB with HIV/AIDS infection, perceived causes and spread of 
TB, outdated social beliefs and practices about TB, public health practice and discourse, 
health staff‟s fear of contracting TB, self-stigmatisation by TB patients, judgement, 
blaming and shaming TB patients and past experiences with TB. It concluded that “the 
fear attached to TB underlies the beliefs, attitudes, actions and behaviours of the whole 
community when interacting with patients” (Dodor et al, 2008:1050).   
 
The findings of a study conducted in Vietnam revealed that TB non-adherent consider TB 
a dirty disease which mainly affects poor people. The study further highlights that TB 
patients have a tendency of not disclosing the disease for fear of being discriminated 
against; and this may lead to a delay in seeking treatment (Hoa et al, 2003). 
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2. 7 MIGRATION 
Migrants are excluded from health services through discrimination. Hence the burden of 
TB is often higher amongst them as compared to the rest of the population (Jack, 2000; 
Karyadi, 2002; Hasker et al, 2008).  
 
Studies conducted in different countries among homeless people revealed that 
immigration requirements had an influence on adherence to treatment. Immigrants on 
treatment were concerned that: TB will affect their immigration status; their illegal 
residence will be discovered when accessing treatment; and they will be incarcerated 
(Volmink & Garner, 2006; Rally et al, 1998; Liam & Tang, 1995). 
 
A quantitative cohort study on default among TB patients on DOTS in Bangalore City 
was conducted among 186 non-adherent registered for treatment between July and 
December 2001. Non-adherents were followed up over a period of time using the 
addresses in the register. In this study migration was cited as one of the reasons for 
default (29%), drug-related reasons such as bulk tablets and vomiting (42%), work-
related conditions such as inconvenient opening hours (15%), stigma (4%) 
(Jaggarajamma et al, 2007). 
 
2. 8 ACCESS TO HEALTH SERVICES 
In most studies, access to a health care facility is dependent on distance and available 
transport as well as physical condition (Khan et al, 2005; Jack, 2000; O‟Boyle et al, 
2002; Thiam, 2007; Jaggarajamma et al, 2007). One study that investigated whether 
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access to a health facility is associated with default indicated that although the intention 
was for the DOT supporter to visit the patient‟s home, in practice the patient had to walk 
to the supporter‟s home (Hill & Chamachandran, 2006). Another study also noted that 
access to health care services was better in urban areas than in rural areas (Jack, 2000).  A 
study conducted by Salaniponi et al, (2000) on care-seeking behaviour showed that 70% 
of respondents who visited an orthodox medical centre stated that it was the nearest place 
to home. However, Khan et al (2005) reported that patients found private practitioners to 
be more accessible than public practitioners‟ hence better adherence.  
 
Several studies have highlighted numerous health system-related factors associated with 
treatment default, and these included long queues, long waiting time, lack of privacy, 
inconvenient appointment time and poor upkeep of clinics were identified as reasons for 
defaulting from treatment (Khan et al, 2005; Thiam, 2007; O‟Boyle et al, 2002; Volmink 
& Garner, 2006).  Some studies found that patients experience difficulties in accessing 
treatment at health facilities because of inconvenient opening hours and provider 
absenteeism (Jack, 2000; O‟Boyle et al, 2002).  
 
A quantitative study conducted in Senegal that investigated the reasons for default among 
newly-diagnosed TB patients showed that patients in the intervention group were 20% 
more likely to be cured from TB than controls (AOR 1:20). About 57% were less likely 
to have defaulted treatment (AOR 0.43; 95% CI 0.21 – 0.89). The intervention 
significantly delayed defaulting when compared to the control group (RR 0.19, 95% CI 
0.07-0.49). This study highlighted a number of reasons for default, namely poor 
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communication between health workers and patients, poorly applied DOTS, inadequate 
follow-up and poor supervision of local treatment centres (Thiam, 2007). 
 
In conclusion, adherence to treatment is a function of family support, good knowledge 
about various aspects of TB, a positive attitude towards TB treatment, awareness of the 
dire consequences associated with non-adherence to treatment and other factors. On the 
other hand, lack of information about side effects, inaccessible health services, negative 
attitude of patients and other factors perpetuate non-adherence to treatment. 
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CHAPTER 3 
 
3.  INTRODUCTION 
Chapter three presents the research methods used in order to achieve the aim and 
objectives of the study. Methodologies, design, sampling procedure, sample size, data 
collection process, data collection tools, as well as data analysis are outlined in this 
chapter. 
  
3. 1 STUDY AIMS AND OBJECTIVES 
3.1.1 AIM 
The aim of the study was to compare knowledge, attitudes and perceptions to TB as a 
disease and its treatment among TB non-adherent and adherent and to describe socio-
economic factors and personal behaviour of non-adherent and adherent. 
 
3.1.2 OBJECTIVES 
 To describe knowledge about TB as a disease among non-adherent and adherent 
 To describe knowledge about TB treatment among non-adherent  and adherent 
 To describe attitudes and perceptions about TB and TB treatment of non-adherent 
and adherent 
 To describe socio-economic factors and personal habits of non-adherent and 
adherent and to compare both groups (non-adherent and adherent) 
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3.2 METHODOLOGY 
3.2.1 STUDY DESIGN 
A cross-sectional survey design was used which sought to describe knowledge, attitudes 
and perceptions about TB as a disease; and its treatment among TB non-adherent and 
adherent at Botšabelo Clinic in Maseru district. The researcher employed the quantitative 
approach to describe knowledge, attitudes and perceptions of TB non-adherent and 
adherent. 
 
The descriptive study yielded accurate and interpretable results. By choosing this kind of 
study, the attitudes, knowledge and perceptions of non-adherent and adherent were easily 
quantified (Terre Blanche & Durrheim, 2006; Polit & Hungler, 1998). 
 
3. 2.2 STUDY POPULATION 
Adult TB patients who were registered in 2007 at Botšabelo Clinic, who were either 
smear positive or smear negative, new, relapses and re-treatment cases and for whom TB 
treatment was initiated were eligible for participation in this study.   
 
3. 2.3 SAMPLE SIZE 
The total population of TB patients in the register for 2007 was 1,686. However, there 
were 247 and 933 registered non-adherent and adherent respectively. Raosoft sample size 
calculator was used to determine the sample size based on the following variables: 
population size from the TB register (that is 247 non-adherent and 933 adherent), 95% 
confidence interval and margin of error of 10%, with the response distribution of 50%. 
Therefore, a recommended sample size was 70 for non-adherent and 88 for adherent. The 
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non-response rate was estimated at 15% - 20%. The sample size was increased by 55% 
after adjustments. Thus, 131 non-adherent and 161 adherents participated in the study. 
 
3. 2.4 SAMPLING PROCEDURE 
Simple random sampling was used. A list of patients (non-adherent and adherent) on the 
TB register at Botšabelo Clinic was used. All patients who met the criteria for the study 
were randomly selected to ensure that every patient had an equal chance of being 
selected. A number was assigned to each study subject: 1-933 for the adherent and 1-247 
for non-adherent. Numbers were written on a piece of paper; all the papers were folded 
and put in a box; a neutral person was assigned to draw numbers from the box; and 
selected numbers were recorded and used as a sample for the study (Terre Blanche & 
Durrheim, 2006). 
 
3. 2.5 EXCLUSION CRITERIA 
Patients below 15 years of age when treatment was initiated and terminally ill patients 
were not asked to participate.  
 
3.2.6 DATA COLLECTION TECHNIQUES AND TOOLS 
Data was collected from February to April 2010. Names and addresses of TB patients 
were obtained from the TB register at Botšabelo Clinic. Individual files and clinic cards 
for patients were examined to identify any discrepancies in recording.  The variable 
treatment outcome was used to identify whether the patient completed or defaulted 
treatment. The interviewers used residential addresses from the register to locate patients. 
A structured questionnaire (Appendix 3) adapted from Advocacy Communication and 
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Social Mobilisation (ACSM) WHO KAP study on TB was used to collect information. 
All individual interviews were face-to-face. 
 
Structured questionnaires were administered in Sesotho and translated into English. 
These interviews were conducted at either the participants‟ homes or at Botšabelo Clinic. 
Participants from the same village were interviewed on the same day as they were 
grouped together according to their villages. Prior to interviews, the interviewers first 
made a courtesy call to the area chief to ask for permission to conduct the study. The 
village health workers were also approached in each village to assist in locating the 
patients. The purpose of the study was explained to the participants in the local language 
as most of them could not speak English. An informed consent form translated into 
Sesotho was handed out to participants (Appendix 2 and Appendix 2a). 
 
Two interviewers were recruited for the study and were trained on how to administer the 
questionnaire to TB patients. 
 
 
3.2.7 DATA ENTRY 
Two data clerks were recruited to enter data and were supervised by the epidemiologist 
and the statistician. Double entry was done to ensure accuracy. The study team (two 
interviewers, researcher, epidemiologist and statistician) reviewed the questionnaires on a 
daily basis. Questionnaires were thoroughly examined by the researcher prior to data 
capture. She appended her signature on correctly filled questionnaires. The improperly 
filled ones were sent back to data collectors for corrections where the interviewee can be 
reached, otherwise they were replaced.  
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3. 2.8 DATA ANALYSIS  
Epi-Info Version 3.4.3 was used to analyse data. For open-ended questions coding was 
done to make analysis easy. Descriptive statistics were calculated using frequencies, 
percentages, proportions and means for socio-demographic information and for 
knowledge, attitudes and perceptions of both non-adherent and adherent. Medians, Inter-
quartile Range (IQR) were used where distribution was not normal.  
Chi square test was run on all variables. P-value of less than 0.05 was accepted as being 
statistically significant in all statistical tests.  
 
3. 2.9 PILOT STUDY 
A pilot study was conducted at Scott Hospital in February 2010. This area was not 
included in the study. Its main purpose was to familiarise the researcher with the research 
environment; and to assist her in identifying potential problems with the design. The pilot 
study was carried out under different environmental conditions of the research but at a 
different place. The questionnaire was altered slightly after it was pre-tested. Thirty 
questionnaires were administered during this process. 
 
3. 2.10 VALIDITY  
Validity refers to the degree in which a measure does what it is intended to do (Terre 
Blanche & Durrheim, 2006). Internal validity refers to the extent to which the effect 
detected in a study is a true reflection of a reality, rather than extraneous variables (Polit 
& Hungler, 1998). Internal validity in this study was assured by the fact that questions 
were asked in the local language and back translated to English because of the low level 
of education among respondents. The questionnaire was pre-tested before it was 
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administered to study subjects. During this process potential problems were identified 
and corrected. 
 
External validity is the extent to which the study findings can be generalized beyond the 
confines of the design and study settings (Terre Blanche & Durrheim, 2006). The 
questionnaire was adopted from ACSM KAP STUDY (WHO, 2008). It comprised of a 
variety of semi-structured, close and open-ended questions. Some questions were 
modified and simplified by the researcher to suit the study. To assess the knowledge 5 
point Likert scale was used ranging from strongly agree to strongly disagree. Selection 
bias was addressed by including all non-adherent and adherent in the study and by 
applying simple random sampling. The information lost due to recall bias was made up 
by collecting the same information from treatment cards. The non-response rate was 
limited to between 15% and 20%. 
 
3.2.11 RELIABILITY 
Reliability is the extent to which the instrument yields the same result on repeated trials 
(Terre Blanche & Durrheim, 2006). In this study reliability was assured by using pre-
tested questionnaire. A two day training of interviewers was conducted by the researcher 
a week before commencement of the study. They were handed guidelines on 
administering a questionnaire. In addition, they were taken through the questionnaire step 
by step, item by item. Grammatical errors were also corrected during the workshops. 
They (interviewers) were former employees of the Ministry of Health with a wealth of 
experience in public health services. Data clerks were full-time employees of the 
Ministry and they were jointly supervised by the epidemiologist and the statistician.  
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3.2.12 GENERALISABILITY 
Due to the fact that the study site (Maseru district) is an urban and peri-urban setting, the 
context in relation to other districts is not similar in terms of lifestyles and the 
environment. Therefore, the results of this study may not be generalised beyond the 
population group under study. 
 
3.3 ETHICAL CONSIDERATIONS 
Participation in this study was voluntary to all respondents. Participants were provided 
with a documented explanation of the research study. Those who agreed to participate in 
the study were asked to sign a consent form. They were adequately informed regarding 
confidentiality of the study and that they had the right to withdraw from the research 
process at any time, without giving any reasons. Moreover, refusal to participate did not 
preclude him/her from receiving treatment. Permission to conduct a study was obtained 
from the Ethical Committee of the University of the Western Cape, the Ministry of 
Health and Social Welfare and Management of Botšabelo Clinic. 
 
All interviewees were assigned a study identification number. After the interviews, 
interviewers checked the health book to see if non-adherent went back for treatment. 
Most non-adherent had already completed their TB treatment. Some were still on 
treatment as there were relapses and most were MDR patients who had defaulted 
treatment before. Many patients were easily identified at the clinic on clinic days and 
others were interviewed in their homes.  
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3.4 STUDY LIMITATIONS 
Tracing non-adherent and adherent in their villages was a challenge because the subjects 
under study completed their treatment in 2009.  Most patients migrated to other villages; 
and the addresses in the register were incomplete. Hence it was difficult to locate them. 
Nine adherents who were followed up in their homes succumbed to HIV infection. 
Treatment outcomes were improperly recorded; most patients who were reported to have 
defaulted had actually completed treatment or died. Patients were replaced by going 
through the same process of random sampling. Due to the high prevalence of HIV (76% 
co-infection) most of the patients had died. Another limitation was that most non-
adherents were relapses and re-treatment cases.  Hence, their inclusion might have caused 
selection bias. The study was subjected to information bias since the practices are self 
reported the respondents may have reported what they think they were supposed to be 
doing and not what they actually do in real life.  
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CHAPTER 4 
4.  INTRODUCTION 
The total population of TB patients in the register for 2007 was 1,686. However, there 
were 247 non-adherent and 933 adherents. 506 TB patients fell under the category not 
evaluated and died. Raosoft sample size calculator was used to determine the sample size. 
A recommended sample size was 70 for non-adherent and 88 for adherent. The sample 
size was increased by non-response rate of 15% - 20% to 64 non-adherents and 106 
adherents.  Furthermore it was increased by 55% after adjustments resulting with 131 
non-adherent and 161 adherents were expected to participate in the study. However, 9 
adherents died before commencement of the study. Hence, they were reduced to 152. 
 
 
Figure 1:  Sample size realization 
Number of TB patients 
registered in 2007 
(1,686) 
Non-adherent 
(247) 
 
Adherent 
(933) 
Not evaluated and died 
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Non-adherent 
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(88) 
 
 
Adherent 
(106) 
Non-adherent 
(84) 
 
 
Non-adherent 
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Adherent 
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Figure 2: Distribution of respondents 
 
 
4.1 DEMOGRAPHIC CHARACTERISTICS OF PARTICIPANTS 
Most respondents (62% of non-adherent and 80% of adherent) came from urban areas 
and mostly from Maseru (76% of non-adherent and 87% of adherent) and Berea (13% of 
non-adherent and 9% of adherent) (Fig. 3). 
 
More males (60% of non-adherent and 55% of adherent) than females participated in this 
study. The median age for non-adherent and adherent was 38.0 (IQR: 29-47) and 40.0 
(IQR: 31-50) years, respectively. 
 
Most respondents were married (73% of non-adherent and 78% of adherent).  
 
Most respondents (92% of non-adherent and 89% of adherent) had some level of formal 
education. A higher number of adherent (57%) than non-adherent (52%) had primary 
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education; a further (31%) and (24%) of non-adherent and adherent, respectively, had 
secondary level education while (9%) non-adherent and (7%) adherent had tertiary level 
education.  
 
      
Figure 3: Distribution of respondents by district                                   
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Table 2: Socio-demographic characteristics of the respondents 
 
Characteristics Non-adherent (131) Adherent (152)   
 
 
Frequency         
Percentage 
Frequency Percentage P-
Value 
Geotype 
   
  0.001* 
Rural 
 
50 38% 30 20% 
 Urban 
 
81 62% 122 80% 
      
 
Sex 
     
0.5 
Male 
 
78 60% 84 55% 
 Female 
 
53 40% 68 45% 
  
      Age (in years) 
    
0.5 
<20 
 
5 4% 0 0% 
 20-29 
 
29 22% 28 18% 
 30-39 
 
36 27% 44 29% 
 40-49 
 
35 27% 39 26% 
 >49 
 
26 20% 41 27% 
 
       Marital status 
    
0.4 
Single 
 
36 27% 34 22% 
 Married 
 
95 73% 118 78% 
 
       Level of education 
   
0.6 
No formal education 11 8% 17 11% 
 Primary 68 52% 87 57% 
 Secondary 40 31% 37 24% 
 Tertiary 12 9% 11 7% 
 
      Employment Status 
   
0.02* 
Employed 69 53% 58 38% 
 Unemployed 62 47% 94 62% 
 
      Live in a brick house 121 92% 146 96% 0.3 
      Spent >6 months outside the 
country 30 23% 30 20% 0.6 
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4.2 HEALTH AND RELATED BEHAVIOURS 
Most respondents (non-adherent 88% and adherent 94%) experienced health workers as 
welcoming and positive. Most adherent (80%) and non-adherent (73%) accepted the 
illness without fear, and disclosed (74%) their disease to a significant number of people 
other than non-health workers. An equal percentage of non-adherent and adherent (93%) 
went to a health facility first for treatment. Less than half of adherent sought treatment 
immediately. More adherent‟ (91%) than non-adherent‟ (87%) homes were within a 5km 
radius or more from the clinic. Concomitantly, more adherents (77%) than non-adherents 
(60%) walked to the clinic. Less than half of non-adherent and adherent were smokers 
and consumers of alcohol (47%). Most non-adherent (86%) and adherent (84%) 
mentioned that their communities support TB patients; and most non-adherent (85%) and 
adherent (76%) said TB infection had not affected their marital status negatively. The 
most common side effects among respondents were vomiting, skin rash and nausea. 
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Table 3:  Health-related attitudes and behaviour 
 
Characteristic Non-adherent (n=131) Adherent (n=152)    
 Frequency Percentage Frequency Percentage P-
Value 
Experienced health workers as positive and 
welcoming 123 88% 147 94% 0.3986 
      Had no fear when diagnosed with TB 95 73% 118 80% 0.3921 
      Disclosed their TB status 97 74% 113 74% 0.9547 
      Went to health facility for treatment 122 93% 142 93% 0.9222 
      Sought treatment immediately 60 46% 87 57% 0.4785 
      Live 5km or more from clinic 114 87% 138 91% 0.4118 
      Walked to the clinic 78 60% 117 77% 0.0024* 
      Smokers 62 47% 72 47% 0.9946 
      Consumers of  alcohol 62 47% 65 43% 0.5157 
      Experienced  support from the community 91 86% 107 84% 0.9681 
      TB infection did not affect marital status 
negatively 80 85% 90 76% 0.8442 
      Side effects experienced: 
   Vomiting 65 64% 46 46% 
 Skin rash 40 44% 59 53% 
 Nausea 39 44% 53 51% 
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4.3 KNOWLEDGE ABOUT TB AND ITS TREATMENT 
Radio, health workers and other media were the main sources of information about TB 
(Fig. 4).  
Responses to knowledge about TB and its treatment were as follows: 
Non-adherent (53%) and adherent (47%) knew the definition of TB. Most respondents 
(99% of non-adherent and 98% of adherent) knew that TB can be transmitted through 
coughing. 
 
Knowledge about symptoms of TB among respondents was excellent. Non-adherent 
(94%) and adherent (93%) knew at least three symptoms of TB. Many non-adherent 
(98%) and adherent (100%) knew that TB is curable, and that TB is cured by TB drugs 
only (97% non-adherent and 99% adherent). Non-adherent (87%) and adherent (99%) 
demonstrated correct knowledge of DOTS.  
 
Non-adherent (99%) and adherent (100%) knew that TB drugs should be taken for six 
months without stopping. Many respondents (91% of non-adherent and 84% of adherent) 
knew at least three preventive measures of TB.  
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Figure 4: Sources of information about TB 
 
Table 4: Knowledge about TB and its treatment 
  
Non-adherent 
(n=131) Adherent (n=152) P-value 
  Frequency (%) Frequency (%)   
  
    Knew the definition of TB 69 53% 71 47% 0.3784 
      Knew that TB is spread through coughing 130 99% 149 98% 0.7225 
      Can identify 3 symptoms of TB 123 94% 141 93% 0.8882 
      Knew that TB is curable 128 98% 152 100% 0.1013 
      Knew that TB can be cured by TB drugs 127 97% 151 99% 0.5444 
      Had correct knowledge of  Direct Observation 
Treatment 114 87% 150 99% 0.0002* 
      Knew that treatment duration is six months 130 99% 152 100% 0.9406 
      Correctly identified TB prevention 78 91% 107 84% 0.0738 
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Non-adherents were asked to give one reason for defaulting treatment. The most 
commonly reported reasons for defaulting were side effects (23%), long duration of 
treatment (13%), lack of transport (12%) and lack of funds (11%) abusing alcohol (4%); 
and smoking (3%)  (Fig. 5).  
 
Figure 5: Reasons for defaulting treatment 
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CHAPTER 5 
5. RESULTS 
5.1 INTRODUCTION 
This chapter presents the findings of the study. The study sought to assess knowledge, 
attitudes and perceptions of TB non-adherent and adherent at Botšabelo Clinic in Maseru, 
Lesotho. 29% of TB patients defaulted treatment at Botšabelo Clinic. Defaulting 
treatment may lead to the development of MDR-TB which is the most difficult form of 
TB to treat. Patients who are knowledgeable, and have good attitudes and perceptions 
about TB are less likely to default treatment (Karyadi, 2002; Khan, et al, 2005). 
 
5.2 DEMOGRAPHIC CHARACTERISTICS OF PARTICIPANTS  
There were 283 respondents in this study, and 131 (46%) were non-adherent while 152 
(54%) of the respondents were adherent. Nine adherents died prior to commencement of 
this study (3%). The sample size was within acceptable limits because it was inclusive of 
15-20% none response rate. 
 
Many respondents (76% of non-adherent and 87% of adherent) were from Maseru, while 
Berea was the second largest residential area with 13% non-adherent and 9% adherent. 
The majority of non-adherent (62%) and adherent (80%) came from urban areas. 
Defaulting treatment varied by area, p-value=0.001. The Lesotho rural areas are 
mountainous with a challenging terrain particularly for patient travel. They are connected 
by footpaths and unmaintained gravel roads. Hence patients cannot easily access outreach 
posts. Urban areas are populated and are characterized by a network of good roads and a 
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booming textile industry. Industrial workers are prone to non-compliance most of the 
time because the nature of their work does not easily allow the time to collect their 
medication. On the day they go to collect their medication they lose their daily payment.    
 
More males (60% of non-adherent and 55% of adherent) than females participated in this 
study. According to Ministry of Health TB Report (2007), more males than females 
suffered from TB. This can be attributed to the fact that Basotho men are migrant workers 
in South African mines and they might have contracted the disease while they were 
miners as result of the nature of their work and living conditions (NTP, 2007).  
The respondents‟ age ranged from 16 to 70 years. The median range for non-adherent and 
adherent was 38.0(IQR=29-47) and 40.0(IQR=31-50) respectively. Defaulting was 
highest in the 30-39 and 40-49 age categories. This group of defaulters was likely to 
engage in risky behaviours such as smoking and abusing alcohol. Many studies found that 
treatment default is dependent on smoking and alcohol abuse (Dujaili, Sulaiman, Awaisu, 
Muttalif & Blebil, 2010; Leung, Yew, Chan, Tam & Lam, 2003; Mauraya, Vijayan & 
Shah, 2002).  Furthermore this age group is more economically active and may 
therefore be involved in job seeking, thus may default as treatment may interfere with 
chances of acquiring employment.   
 
Most respondents were married (73% of non-adherent and 78% of adherent). Most 
respondents had some level of formal education (92% of non-adherent and 89% of 
adherent). A higher number of adherent (57%) than non-adherent (52%) had primary 
education; a further (31%) and (24%) of non-adherent and adherent, respectively had 
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secondary level education. Interestingly more non-adherent (9%) had tertiary education 
as compared to adherent (7%).  
 
More adherents (62%) were unemployed. While only 53% of non-adherents were 
employed, p-value=0.02. This could be attributed to the fact that the unemployed have 
more time to visit clinics than the employed. The latter have to seek permission from 
their employers for them to visit clinics. Contrary to the findings of this study, Hasker et 
al (2008) found that most non-adherent were unemployed.   Stigma attached to the 
condition especially in the workplace may further result in employees not disclosing their 
condition and therefore be unable to disclose to employers about the treatment thereof.   
 
Non-adherent (92%) and adherent (96%) lived in brick houses. In most studies conducted 
in Africa, TB is common among people who live in informal settlements, where there is 
overcrowding and poor living conditions (Wandalo & Mokve, 2000; Dodor et al, 2008; 
Salaniponi et al, 2000). Contrary to the findings of other studies, this study found that 
patients lived in good houses. Very few non-adherent (23%) and adherent (20%) had 
been out of the country. Migration did not influence defaulting treatment in this study.  
 
5.3 HEALTH-RELATED ATTITUDE AND BEHAVIOURS 
Many non-adherent (88%) and adherent (94%) reported that the attitude of health 
workers was welcoming/positive with a p-value of 0.4. This is in line with findings of  
other studies conducted by Mushtaq et al, 2010; Liam et al, 1999; Khan et al, 2006 which 
found that health workers had positive attitude towards TB patients. Contrary to the 
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findings of this study, some studies revealed negative attitudes among health workers 
(Mohamed et al, 2007; Bam et al, 2006; Dodor et al, 2008). 
 
The results of this study found that 73% of non-adherent and 80% of adherent accepted 
their illness without fear. Most of them knew that TB is curable. TB seems not to carry 
much stigma anymore. The findings of the study conducted in Malaysia among newly-
diagnosed tuberculosis patients  showed that 49% of TB patients expressed that they were 
not too worried, 22% were shocked that they had TB and 22%  feared when they were 
told they had TB (Liam et al, 1999).  
 
Many non-adherent (93%) and adherent (93%) went to a health facility for treatment. 
Only 7% of non-adherent and adherent consulted traditional healers. Only few patients 
went to traditional healers for treatment despite them playing an important role in 
Lesotho in the treatment of TB (LDHS, 2004). However, respondents may not have 
reported the use of traditional healers as they might have been warned about the 
interaction of drugs and traditional medicine.  A study conducted in South Africa found 
that respondents did not report the use of traditional medicine due to stigma attached to 
using traditional practices (Nxumalo, Alaba, Harris, Chersich & Goudge 2011).  
  
Non-adherent (46%) and adherent (57%) sought treatment immediately when they felt 
sick. There seems to be problems around accessing treatment early. This may be because 
coughs are common in Lesotho, and hence may not be associated with TB therefore 
resulting in delays in seeking treatment. According to Mushtaq et al, (2010), 78% of TB 
patients sought treatment as soon as symptoms occurred while others (17%) would wait 
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until after 3-4 weeks. The 78% comprised people with high school education, high 
income, good housing and better knowledge of symptoms of TB. 
 
Significantly more adherent (77%) than non-adherent (60%) walked to the clinic, p-
value=0.002. This could be attributed to the geographical terrain of the country.  
Adherent (87%) and non-adherent (91%) lived 5km or more away from the clinic, p-
value=0.41.  Other studies found that health-seeking behaviour is influenced by distance 
to the clinic and availability of funds for transport (Khan et al, 2005; Jack, 2000; Luis et 
al, 2011). 
 
A study conducted in Malawi which looked at care-seeking behaviour among patients 
with smear positive TB, found that 70% of TB patients who first visited  orthodox 
medical care walked to the clinic and they cited proximity to home as a reason for 
visiting the centre (Salaniponi et al, 2000). 
 
An equal percentage of non-adherent (47%) and adherent (47%) smoked, while 47% of 
non-adherent and 43% of adherent drank alcohol. Smoking, alcoholism and drug abuse 
have been found to increase treatment default (Sepa & Peltzer, 2005; Dujaili et al, 2010; 
Mauraya et al, 2002; Leung et al, 2003; Hasker et al, 2008). Studies have revealed that 
drinking alcohol coupled with poor nutrition can cause side effects (Dujaili et al, 2010).   
Furthermore, a study conducted by Pandit & Chaudhary in 2006 reported that drinking 
alcohol was associated with unpleasant side effects such as vomiting. Patients who 
experience side effects are more likely to default TB treatment (Khan et al, 2000). 
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Many non-adherent (86%) and adherent (84%) knew of the presence of TB patients in 
their communities and that such patients are supported by those communities. In Lesotho, 
TB patients are supported by trained DOT supporters in their communities. This was 
reinforced by the study conducted by Mushtaq et al, (2010) which found that society was 
supportive of TB patients. Contrary to the findings of this study, Dodor et al, (2008) 
revealed that TB patients were stigmatised and rejected by the community. 
 
The most commonly-reported side effect by non-adherent (64%) was vomiting, while 
more than 50% of adherent reported skin rash. Patients who experience side effects 
during treatment are likely to not comply with treatment (Homedes & Ugaide, 1993). 
Many studies have shown that side effects are the most common cause of treatment 
default (Volmink & Garner, 2006; Khan et al, 2000; O‟Boyle et al, 2002; Homedes & 
Ugaide, 1993). In addition, other studies have cited adverse reaction to treatment, lack of 
information about side effects and how to overcome them as reasons for discontinuing 
medication (O‟Boyle et al, 2002; Pandit & Chaudhary, 2006). Furthermore, one study 
conducted in India revealed that one of the reasons for perceived side effects could be the 
continued practice of taking medication on an empty stomach (Vijay et al, 2010). 
 
5.4 KNOWLEDGE ABOUT TB AND ITS TREATMENT 
The sources of information in this study varied. Non-adherent (53%) and adherent (47%) 
heard about TB from the media (radio, TV and newspapers); 27% of non-adherent and 
29% of adherent got information from friends, relatives, neighbours and patients‟ 
record/book (Bukana). The media was the most utilised source of information in this 
study. None of the respondents reported billboards as a source of information. Less than 
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25% of non-adherent and adherent in this study reported health workers as a source of 
information. Many studies have revealed that radio and television are good sources for 
disseminating health information (Bam et al, 2006; Mohamed et al, 2007; Mushtaq et al, 
2010; Liam et al, 1999; Yadav et al, 2006). 
 
Non-adherent and adherent, 53% and 47%, knew the definition of TB, respectively. This 
was reinforced by the studies conducted by Mohamed et al, 2007; Liam et al, 1999; 
Mushtaq et al, 2010; Khan et al, 2006  which showed that the majority of respondents 
knew that TB is caused by a germ. 
 
Many non-adherent (91%) and adherent (84%) could at least identify three symptoms of 
TB. The high level of knowledge about symptoms may be a result of ongoing educational 
campaigns. This is in line with the findings of other studies where respondents possessed 
excellent knowledge about symptoms of TB (Bam et al, 2006; Mohamed et al, 2007; 
Mushtaq et al, 2010; Liam et al, 1999; Yadav et al, 2006). Although  knowledge did not 
influence adherence in this study, an Angolan study that measured the parameters of 
health-seeking intention among TB patients found that knowing the key symptoms of TB 
was positively associated with appropriate health-seeking (OR 3.1, 95% CI 1.4-6.8) (Luis 
et al, 2011). 
 
The study found that among those who could not define TB there were misconceptions 
about the cause of TB, and causes mentioned included poison (sejeso). This is in line 
with studies conducted by Khan et al, 2006; Mushtaq et al, 2010; Hoa et al, 2003; and 
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Yadav et al 2006 that found that TB patients believed that TB is caused by cold and dirty 
air. 
 
The majority of respondents demonstrated good knowledge of transmission of TB. Many 
non-adherent (97%) and adherent (99%) mentioned coughing as a way of transmitting TB 
(Mohamed et al, 2007; Mushtaq et al, 2010; Liam et al, 1999; Yadav et al, 2006). 
 
Numerous studies have revealed a link between knowledge and default (Hill & 
Chamachandran, 1992; Homedes & Ugaide, 1993; Jaiswal et al, 2000; Khan et al, 2000; 
Bam et al, 2006; Liam et al, 1999; Jaggarajamma et al, 2007). Knowledge includes the 
ability to: recognize symptoms; identify causes and transmission routes; and familiarise 
one with the availability of cure and duration of treatment (WHO, 2008b).  
  
When asked whether TB is curable, 98% of non-adherent and 100% of adherent knew 
that TB is curable. A study by Liam and colleagues (1999) found that those who knew 
that TB is curable were likely to comply with treatment. Most non-adherent (97%) and 
adherent (99%) mentioned that TB can be cured by TB drugs only. This is in line with 
studies conducted by Mohamed et al, 2007; O‟Boyle et al, 2002; Thiam, 2007; and 
Jaggarajamma et al, 2007 where the majority of patients possessed good knowledge 
about the treatment of TB. 
 
Non-adherent (99%) and adherent (100%) knew that TB treatment is taken for six months 
without interruption. Some studies showed that adherence was found mainly where 
people understood the importance of long treatment (Khan et al, 2000; O‟Boyle et al, 
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2002; Bam et al, 2006). Contrary to the findings of other studies, this study found that 
non-adherent was knowledgeable that the duration of treatment is six months.  
 
Respondents were asked to define Direct Observation Treatment (DOT). Most of them 
(87% of non-adherent and 99% of adherent) excellently defined DOT, p-value=0.0002.  
Knowledge and practice are in discordance here because high knowledge does not yield 
expected practice. Some studies found that patients who are observed during treatment 
are more likely to adhere to it (Homedes & Ugaide, 1993; Jaiswal et al, 2000). 
 
When asked about the prevention of TB, non-adherent (91%) and adherent (84%) 
demonstrated good knowledge of ways of preventing TB infection. On the one hand, it 
was worrying to see that some patients still believed that TB infection can be prevented 
by not sharing dishes. This suggests that stigma may still be present in the community.  
Furthermore, other respondents mentioned praying and practising safe sex as preventive 
measures for TB infection. Such findings suggest that there are knowledge gaps 
regarding TB. Liam et al, 1999; Yadav, et al 2006; Khan et al, 2006; and Pronyk et al, 
2001 found that knowledge about the spread of TB was limited and patients had 
misconceptions that TB was spread by sharing dishes; and nearly half of the patients  
avoided eating with their family for fear of contracting the disease. In one study stigma 
was associated with treatment default. It also found that TB patients have a tendency of 
not disclosing the disease for fear of being discriminated against; and this may lead to a 
delay in seeking treatment (Hoa et al, 2003). 
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In this study, non-adherent‟ reasons for discontinuing treatment included the following: 
side effects (23%); long treatment (13%); lack of transport (12%); lack of funds (12%); 
abusing alcohol (4%); and smoking (3%) when I felt better (5%) long duration of 
treatment t(5%) (See Figure 5). The high percentage of non-adherent who abandons 
treatment due to side effects suggests that there is a need for vigorous support especially 
during the early phases of treatment. Furthermore, literacy regarding medication use is 
essential as it will inform clients about side effect and ways to overcome these. 
Management of side effects should be included in the training manuals for community 
health workers. Socio-economic factors such as lack of transport, lack of funds have been 
cited as barriers for completion of treatment in this study. Furthermore the study revealed 
personal habits like smoking and alcohol abuse to be predictors of treatment non- 
adherence. 
 
Studies revealed that patients abandoned treatment because of side effects (Volmink & 
Garner, 2006; Khan et al, 2000; O‟Boyle et al, 2002; Imdad, Newell & Walley, 2000; 
Homedes & Ugaide, 1993). This was also confirmed by Pandit & Chaudhary 2006; Vijay 
et al, 2010).  
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CHAPTER 6 
 
6.  INTRODUCTION 
This chapter presents the conclusion of the study. A set of recommendations for 
improvement are presented. 
 
6.1 CONCLUSION 
Non-adherent and adherent showed good knowledge of symptoms, prevention, disease 
transmission and definition of TB. Even though many could define TB, there were 
misconceptions that TB is caused by poison. Therefore, there is a need to strengthen 
health education on TB among communities. They were also knowledgeable that TB is 
curable and many could define DOT. Their attitudes and perceptions towards TB as a 
disease were positive. Many (93%) of those who were diagnosed with TB went to a 
health facility for treatment, while others sought it from traditional healers. A 
considerable number of non-adherent and adherent were heavy smokers. Alcohol intake 
was moderate among both groups. 
 
Media was reported as the main source of TB information in this study. Side effects to 
medication were the most reported deterrent to treatment among non-adherent. The side 
effect with the highest frequency was vomiting. It was followed by nausea and skin rash.  
Socio-economic factors that determined treatment default were access to health services, 
long distance to the clinic, lack of transport and lack of funds and personal habits like 
smoking and alcohol abuse. Delay in seeking treatment was found to be a problem in this 
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study. There was no difference found between knowledge, attitude and perceptions of 
adherent and non-adherent. 
 
6.2 RECOMMENDATIONS  
The researcher proposes the following interventions to the Ministry of Health and Social 
Welfare in Lesotho: 
 Improve access to health services. Encourage professional health workers to 
accompany community health workers on their home visits. 
 Provide patients with transport subsidies. Encourage Community Health Workers 
to conduct home visits for critically ill patients. 
 Include management of side effects in the community health worker manual. 
Educate patients to manage side effects in their homes.  
 Merge HIV and TB programmes. Create national coordinating body. 
 Conduct a study to explore the role of traditional beliefs in communities regarding 
Tuberculosis.  
 Conduct a workshop to determine factors influencing delay in seeking treatment 
among TB patients 
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APPENDIX 1 
 
 
 
UNIVERSITY OF THE WESTERN CAPE 
School of Public Health 
 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
Tel: 021- 959 2809, Fax: 021- 959 2872 
        
 
PARTICIPANT INFORMATION SHEET 
 
TITLE OF RESEARCH 
Knowledge, attitudes and perceptions of TB non-adherent and non- defaulters in Maseru 
district, Lesotho 
 
What is the study about? 
This is a research project being conducted by Dr. Moselinyane Letsie of the University of 
the Western Cape. We are inviting you to participate in this research project because you 
defaulted on TB treatment or you suffered from TB for more than two months according 
to the TB register.  
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What is the purpose of this study? 
The purpose of this research project is to examine non-adherent‟ and non defaulter‟s 
perceptions with regard to TB and to assess their knowledge and attitudes and perception 
towards TB as a disease and its treatment. This study will provide information that would 
inform the development of evidence-based practice. 
 
What will I be asked to do if I agree to participate?  
You will be asked to respond to questions listed below only after you have agreed to 
participate in the interview. The interview will not take more than ten minutes of your 
time. These interviews will be conducted in your homes and/or at Botšabelo Clinic. The 
questions will be as follows: 
 What is your name? 
 Where do you live? 
 How old are you? 
 Can you read and write in your own language only?  
 Do you smoke and/or take beers/spirits/brandy/whiskey? 
 How far is your home from the clinic? 
 Do you know anything about TB? 
 How are TB patients treated in the community in which you live? 
 
Would my participation in this study be kept confidential? 
We will do our best to keep your personal information confidential. To help protect your 
confidentiality, we will refer to you by a pseudonym or invented name which we would 
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like you to choose. We shall keep any other records of your participation locked away at 
all times. Your name will not be included on the survey or other collected data; a code 
will be placed on the survey questionnaire; through the use of identification key, the 
researcher will be able to link your name to your identity; and only the researcher will 
have access to the identification key. 
If we write a report or article about this research project, your identity will be protected to 
the maximum extent possible. 
 
QUESTIONS 
Direct your queries with regard to this research study to: 
Dr. Moselinyane Letsie 
E-Mail: lmosilinyane@yahoo.com 
Telephone: 00266 22312501(W), 00266 22321106(H) 
Fax Number: 00266 22317103(W) 
 
My supervisor is Lungiswa Tsolekile of University of the Western Cape. Her contact 
detailsare: 021 959 2809; her e-mail address is ltsolekile@uwc.ac.za 
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APPENDIX 1A 
 
TSEBISO KA LIPATLISISO HO BA NKANG KAROLO 
 
Thlakubele 2010  
 
Monghali/Mofumahali Ea Ratehang, 
 
SEHLOOHO SA LIPATLISISO 
Tsebo, litloaelo le maikutlo a   bakuli ba lefuba seterekeng sa Maseru naheng ea Lesotho, 
ba sitiloeng ho qeta litlhare tsa bona ka nako e neng e behiloe.(likhoeli tse tseletseng) le 
ba qetileng litlhare tsa bona ka nako. 
 
LIPATLISISO TSEE KE TSA ENG? 
Lipatlisiso tsena ke tse etsoang ke Dr Moselinyane Letsie oa University ea Kapa 
Bophirima.Re o memela ho kenala lipatlisiso tsena  hobane  ho fumanehile hore o e mong 
oa bakuli basa qetang lithlare tsa lefuba ka nako ea likhoeli tse  tseletseng, ka hona o 
khethuoe ho tla araba lipotso. 
 
SEPHEHO SA  LIPATLISISO TSEE KE ENG? 
Sepheho ke ho phenya bakuli ba lefuba maikutlo malebana le ho nyahlatsa pheko ea lefu 
lena kahare ho nako; le ho fumana ka botebo seo ba se tsebang ka lefu lena, „moho le 
litloaelo tsa bona. Sena se tla fokotsa sekhahla seo bakuli ba lefuba  ba tlohelang pheko 
 
 
 
 
  
 
73 
 
ka sona pele ho nako (ea likhoeli tse tsˇeletseng) le hontlafatsa lefapha la lefuba lekaleng 
la bophelo. 
 
SE LEBELETSOENG HO ‘NA KE SEFE HA KE KENELA LIPATLISISO TSEE? 
Se lebeletsoeng ho oena ke hore o tla araba lipotso mabapi le lipatlisiso tsena haeba o 
lumela ho kenela lipatlisiso. Nako ea lipotso e tla ba metsotso e leshome le metso e 
mehlano feela.Lipotso Li tla botsetsoa lapeng la hao le tliliniking ea Botšabelo. 
Lipotso lit la botsoa ka mokhoa o latelang: 
Lebitso la hao ke mang? 
O lula kae? 
Lilemo tsa hao li kae? 
O tseba ho ngola le ho bala ka puo ea heno? 
Na oa tsuba? 
O lula hole ha kae le tliliniki? 
O tseba  eng ka lefuba? 
Bakuli ba lefuba ba tsoaroa joang ke sechaba? 
 
NA LITABA TSA KA E TLABA LEKUNUTU LIPATLISISONG TSEE? 
Re tla etsa bo „nete  ba hore litaba tsa hao e tla ba lekunutu. Lebitso la hao lona le tla lula 
ele sephiri. Bo-ralipatlisiso ba tla sebetsa ka linomoro le lebitso la maiketsetso  e seng ka 
lebitso la hao; joalo ka  ha ke se ke boletse lona e tla ba pinyane. Litaba tsa hao ha li na 
ho fetisetsoa ho mang kapa mang ho kenyeletsoa metsoalle ea hao, baheno esitana le 
mohiri oa hao. Lingoloa tsohle tse amanang le lipatlisiso tsena li ke ke tsa e-ba le lebitso 
la hao ho hang.  
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LIPOTSO 
Lipotso li lebisoe ho batho ba latelalang:  
Dr. Moselinyane Letsie 
Nomoro ea sekolo: 2724132 
E-Maile: lmosilinyane@yahoo.com 
Telephone: 00266 22312501(W), 00266 22321106(H) 
Fax Number: 00266 22317103(W) 
 
Mokoetlisi oaka ke Lungiswa Tsolekile oa Junifesithi ea Kapa Bophirima. Linomoro 
tsa  mohala oa hae ke 021 959 2809;  e- mail: ltsolekile@uwc.ac.za.  
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APPENDIX 2 
 
CONSENT FORM 
Title of Research Project: 
The study has been described to me in the language that I understand and I freely and 
voluntarily agree to participate. My questions about the study have been answered. I 
understand my identity will not be described and that I may withdraw from the study 
without giving a reason at any time and this will not negatively affect me in any way. 
 
Participant’s name………. 
Participant’s signature…………. 
Date…………….. 
 
Should you have any questions regarding this study or wish to report any problems you 
have experienced related to the study please contact the study coordinator: 
Study Coordinator‟s Name: Ms Lungiswa Tsolekile 
University of the Western Cape 
Private Bag X17, Belville 7535 
Telephone (021) 959-2809 
Fax: 021-959-2872 
Email:ltsolekile@uwc.ac.za 
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APPENDIX 2A 
TUMELLO EA HO ETSA LIPATLISISO 
Sehloho sa lipatlisiso. 
Ke hlaloselitsoe Lipatlisiso tsena ka botlalo ka leleme la puo ea heso. Ke lumela ho 
kenela lipatlisiso tsena. Lipotso tsaka ka lipatlisiso tsena li arabetsoe. Ke boleletsoe hore  
lebitso laka le tla bolokoa ele lekunutu m‟e leke ke la tsebisoa mang kapa mang,lehore 
nka itokolla neng kapa neng ha ke batla ho se kenele lipatisiso tsena, „me li keke tsa ama 
phekolo ea ka ea lefuba. 
 
Lebitso la ea kenetseng lipatlisiso ….………. 
Tekeno ea ea kenetseng lipatlisiso…………. 
Letsatsi…………….. 
 
Haeba o ka ba le lipotso malebana le lipatlisiso tsena kapa oa lakatsa ho fana ka tlaleho, 
ha u na le mathata ka lipatlisiso tsena, kopana le mohokahanyi atereseng e latelang: 
Mohokahanyi oa lipatlisiso: 
Ms Lungiswa Tsolekile 
University ea kapa Bochabela 
Private Bag X17, Belville 7535 
Mohala: (021) 959-3735 
Mohala oa thekeng: 082 399 5428 
Fax:021-959-2872  
Email:ltsolekile@uwc.ac.za 
 
 
 
 
  
77 
 
APPENDIX 3          
           
QUESTIONNAIRE FOR PATIENTS   
      
1. Identification     
         
101 Name of interviewee_____________________________________________   
        
102 Name of village_________________________________________________ [  ][  ][  ][  ] 
        
103 Survey number-------------------------------------------------------------------------------------- [  ][  ][  ][  ] 
        
104 District________________________________________________________ [  ][  ] 
  Butha-Buthe=1, Leribe=2, Mafeteng=3, Berea=4, Maseru=5,    
  Mohaleshoek=6, Mokhotlong=7, Qachasnek=8, Quthing=9,    
  Thaba-Tseka=10     
        
105 Area__________________________________________________________ [  ] 
  Urban=1, Rural=2     
              
106 Defaulter Yes=1,  No=2  [  ] 
**fill in the blocks and blanks with appropriate answers and numbers   
           
2. Interview visit    
201 Name of interviewer______________________________________________   
            
202 Date D      [  ][  ] 
      M     [  ][  ] 
      Y [  ][  ][  ][  ] 
            
**fill in the blocks and blanks with appropriate answers and numbers   
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3. Demography 
     
No Question/Filter   OPTION/CODING Skip 
301 Age           
               
302 Sex           Male 1   
         Female 2   
               
303 Marital status         Single 1     
          Married               2    
          Separated           3    
          Divorced             4    
          Cohabitant           5    
          Other 6    
                      
**fill in the blocks and blanks with appropriate answers and circle an appropriate number   
      
4. Socio-economic information   
         
No Question/Filter   OPTION/CODING Skip 
401 Occupation         Professional 1     
          Business 2    
          Skilled labourer 3    
          Miner 4    
          Ex-miner 5    
          Farmer 6    
          Pensioner 7    
          Unemployed 8    
          Other(specify) 9    
                 
402 Have you ever attended school?     Yes 1     
          No 2    
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403 If yes, up to which level?       Primary 1     
          Secondary 2    
          Tertiary 3    
          Other(specify) 4    
                
404 Do you smoke?         Yes 1     
          No 2    
                
405 If yes, what do you smoke?       Cigarettes 1     
          Marijuana 2    
          Snuff 3    
          Benzine/glue 4    
                      
                
406 How many cigarettes do you smoke per day?          
                
                
407 Do you take alcoholic drinks?       Yes 1     
          No 2    
                
408 If yes, how often?         Daily 1     
          Seldomly 2    
          Occasionally 3    
          Week end only 4    
                
409 Have you ever been out of the country for a period exceeding        
  six months in a year?     Yes 1    
          No 2    
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410 If yes, state reason.                 
                
                
411 What kind of a house do you live in?     Shack 1     
          Brick house 2    
          Hut 3    
                      
**fill in the blanks with appropriate answers and circle an appropriate number   
           
5. TB attitudes and perceptions     
          
501 How do you think a person infected with TB should be treated?   
  1 Isolate him/her    
  2 Prohibit him/her from attending social functions   
  3 Sympathize with him/her   
  4 Treat him/her like any other normal person   
            
      
502 What was your reaction when you were told you had TB? Circle all correct alternatives.    
  1 Fear    
  2 Surprise    
  3 Shame    
  4 Embarrassment    
  5 Sadness or hopelessness    
  6 Other    
          
          
 
 
 
 
  
 
81 
 
 
503 Who did you talk to about your illness (TB?)   
  1 Traditional doctor    
  2 Medical doctor    
  3 Health worker    
    4 Spouse   
  5 Parent     
  6 Close friend    
    7 No one   
  8 Other     
            
          
504 Where did you go when you were told you had TB?   
  1 Went to health facility     
  2 Went to traditional healer    
  3 Other (Explain)     
            
          
505 How soon did you seek treatment?   
             
  1 Immediately   
  2 When I had  cough for more than two weeks   
  3 When I lost weight     
  4 When the condition did not improve       
  5 Other          
          
             
506 Do you think TB treatment is free?   
  1 Yes   
  2  No   
  3 other   
**Circle an appropriate Number 
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6. Health service related factors   
         
No Question/Filter       
                      
601 How far is your home from the clinic?          
              
    1 0 to 2 km          
    2 2 to 5 km         
    3 5 to 10km         
    4 > 10 km         
            
        
602 Which mode of transport do you usually use?       
             
             
             
             
             
                      
603 Were you satisfied with the service at the clinic?   
         
    1 Yes         
    2 No          
            
        
604 If 603 answered, explain.    
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605 What was the attitude of the health worker towards you?   
             
   1 Positive – Welcoming        
   2 Negative – Ridicule        
   3 Neutral        
   4 Other(specify)        
                      
**fill in the blanks with appropriate answers and circle an appropriate number   
                      
7. Knowledge about TB    
      
No Question/Filter       
              
701 What is TB? Explain.   
         
            
      
      
      
      
             
702 How did you know about TB?         
             
   1 Television         
   2 Radio         
   3 Billboards         
   4 Newspaper        
   5 Health worker        
   6 Religious leader        
  
 
 7 Other         
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703 How is TB transmitted from one person to another?   
              
    1 Coughing         
    2 Sneezing         
    3 Kissing         
    4 Sharing utensils        
    5 Touching    
            
            
704 What are symptoms of TB?           
              
   1 Cough         
   2 Loss of weight        
   3 Oral thrush        
   4 Coughing blood        
   5 Diarrhoea         
   6 Night sweat       
   7 Lymphadenopathy       
   8 Other(specify)       
                    
             
705  TB is  curable          
             
   5 Strongly Agree        
   4 Agree         
   3 Impartial         
   2 Disagree         
   1 Strongly Disagree        
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706 How can someone with TB be cured?        
    1 Herbal medicine        
    2 Home rest without medicine       
    3 TB drugs         
    4 Do not know        
    5 Traditional medicine        
    6 Other(specify)        
                      
             
707 Explain Direct Observation Treatment.        
             
             
             
             
                      
708 TB treatment can be taken continuously for six months without stopping.     
   5 Strongly Agree        
   4 Agree         
   3 Impartial         
   2 Disagree         
   1 Strongly Disagree        
                      
              
709 Did you experience any of the following side effects during treatment? (You can choose more    
  than one answer.)          
    1 Vomiting         
    2 Nausea         
    3 Skin rash         
    4 Blurred vision        
    5 Poor hearing        
    6 Yellow colour of eyes       
    7 Other         
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710 Anybody can be infected with TB        
             
   5 Strongly Agree        
   4 Agree         
   3 Impartial         
   2 Disagree         
   1 Strongly Disagree        
             
                      
711 How can a person avoid TB infection? (tick all appropriate alternatives)     
             
   1 Practising safe sex        
   2 Covering mouth and nose when coughing or sneezing     
   3 Avoid sharing dishes        
   4 Opening windows at home       
   5 Through good nutrition       
   6 By praying        
   7 Other(specify)        
                      
             
712 How serious do you think TB is in Lesotho?        
   1 Very serious        
   2 Somewhat serious        
   3 Not very serious        
   4 Do not know        
                      
**fill in the blanks with appropriate answers and circle an appropriate number    
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8. Stigma         
No Question/Filter                 
801 Do you know anybody who has TB in the community?       
             
   1 Yes         
   2 No         
             
                      
802 How is she/he treated by the community?        
   1 Supported        
   2 Laughed at        
   3 Rejected        
   4 Other         
                      
             
803 When you were initiated on treatment, were you able to take it continuously for six months without   
  failure?          
   1 Yes         
   2 No          
                      
             
803(a) If no, please explain why.         
             
             
                      
             
804 Has TB infection affected your marital relationship negatively?      
   1 Yes         
   2 No         
   3 Do not know        
**fill in the blanks with appropriate answers and circle an appropriate number    
Adopted from ACSM KAP STUDY (WHO,2008a)       
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